By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Gen-Probe announced after the close of the market on Tuesday a 2 percent decline in fourth-quarter revenues as product revenues shrank 3 percent.

The company also announced a $150 million share buyback program.

For the three months ended Dec. 31, 2010, the San Diego molecular diagnostics firm posted overall revenues of $136.7 million, down from $138.9 million a year ago, and short of consensus analyst estimates of $137.9 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genes under positive selection in Plasmodium falciparum populations, genetic variation in Epstein-Barr viruses, and more.

Cancer clinical trial patients settle with Anil Potti and Duke University.

A trio of researchers is trying to raise money to sequence and analyze the genome of a cat with a suite of unusual traits.

Two Johns Hopkins researchers discuss the need for evidence-based data analysis.